Post by Symeres

Moving a small-molecule program from discovery to IND can feel complex, but it doesn’t have to be. When teams combine expertise across medicinal, synthetic, computational, and specialty chemistry from the very start, each step becomes more predictable and data-driven. You gain clarity on which molecules are most promising, ensure compounds can be scaled efficiently, and reduce the risk of delays later in development. Symeres helps your team combine chemistry expertise, share insights, and guide decisions, making each step more predictable and confident. 🔗 Explore our developability roadmap to see how every step of the process can be de-risked: https://brnw.ch/21x32UZ